Keywords: Targacept, AstraZeneca, Amended collaboration, Alzheimer's disease, Cognitive disorders, AZD1446, TC-1734

Targacept regains rights to Alzheimer's drug candidate from AstraZeneca

Article | 06 March 2013

US biopharma drug developer Targacept (Nasdaq: TRGT) and Anglo-Swedish drug major AstraZeneca (LSE: AZN) have amended their collaboration to give ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Targacept

AstraZeneca

Go to company listing

Related Drugs

TC-1734

AZD1446

Go to drug listing